Deals this week: Grifols, Cellesce, Arena Pharmaceuticals
pharmaceutical-technology | April 21, 2017
Spanish pharmaceutical company Grifols has raised €1bn ($1.06bn) through a public offering of bonds. Due 1 May 2025, the unsecured bonds carry a coupon rate of 3.2%.The offering is intended to refinance the bonds issued by the company in March 2014.